Gary E Landreth

Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice.

Michael T Heneka, Thomas Klockgether, Cuno Kuiperi, 2005, Brain : a journal of neurology.

Evidence for impaired amyloid β clearance in Alzheimer's disease

G. Landreth, Kristin R. Wildsmith, Julie C. Savage, 2013, Alzheimer's Research & Therapy.

Activation of the nuclear receptor PPARδ is neuroprotective in a transgenic mouse model of Alzheimer’s disease through inhibition of inflammation

Lauren J Donovan, Gary E Landreth, Tarja Malm, 2014, Journal of Neuroinflammation.

Active PSF Shaping and Adaptive Optics Enable Volumetric Localization Microscopy through Brain Sections

Sheng Liu, Fang Huang, Michael J. Mlodzianoski, 2018, Nature Methods.

Inflammation, Apoptosis, and Alzheimer's Disease

G. Landreth, Gary E Landreth, Maria E Bamberger, 2002, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

ERK/MAPK signaling and autism spectrum disorders.

Joseph Vithayathil, G. Landreth, Gary E Landreth, 2018, Progress in brain research.

Sensory Network Dysfunction, Behavioral Impairments, and Their Reversibility in an Alzheimer's β-Amyloidosis Mouse Model

Donald A Wilson, D. Wesson, G. Landreth, 2011, The Journal of Neuroscience.

Microglia and inflammation in Alzheimer's disease.

G. Landreth, Gary E Landreth, Shweta Mandrekar-Colucci, 2010, CNS & neurological disorders drug targets.

Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase.

Michael T Heneka, Thomas Klockgether, Timothy M Willson, 2003, The Journal of neuroscience : the official journal of the Society for Neuroscience.

The microglial NADPH oxidase complex as a source of oxidative stress in Alzheimer's disease

G. Landreth, B. Wilkinson, Gary E Landreth, 2006, Journal of Neuroinflammation.